GPATU — GP-Act III Acquisition Income Statement
0.000.00%
Last trade - 00:00- $371.80m
- $371.71m
- 42
- 52
- 50
- 46
Annual income statement for GP-Act III Acquisition, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | ||||
| Total Operating Expenses | 0.004 | 0.031 | 0.014 | 0.565 |
| Operating Profit | -0.004 | -0.031 | -0.014 | -0.565 |
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -0.004 | -0.031 | -0.014 | 8.67 |
| Net Income After Taxes | -0.004 | -0.031 | -0.014 | 8.67 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.004 | -0.031 | -0.014 | 8.67 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.004 | -0.031 | -0.014 | 8.67 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0 | -0.001 | -0 | 0.345 |
| Dividends per Share |